Zweig Di Menna Associates LLC Cytokinetics Inc Transaction History
Zweig Di Menna Associates LLC
- $824 Million
- Q2 2025
A detailed history of Zweig Di Menna Associates LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Zweig Di Menna Associates LLC holds 35,600 shares of CYTK stock, worth $1.21 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
35,600Holding current value
$1.21 Million% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
394Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$500 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$404 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$340 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$272 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$208 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.21B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...